Four plaintiffs joined an Actos MDL accusing Takeda Pharmaceuticals and Eli Lilly of causing and failing to warn about Actos bladder cancer.

Two of the plaintiffs allegedly developed serious Actos complications after using the drug to treat type-2 diabetes. The other two plaintiffs joined the Actos bladder cancer lawsuits as their spouses with claims of loss of consortium.

Plaintiff Dennis and Carol C. filed their Actos bladder cancer lawsuit after Dennis was prescribed with bladder cancer in August 2014. Dennis had used the drug for over three years to treat his type-2 diabetes. His wife claims she was “deprived of the comfort and enjoyment of the services and society of her spouse” because of the damages caused by the drug manufacturers.

Plaintiffs Richie S. and his wife Theresa filed their Actos bladder cancer lawsuit after Richie developed bladder cancer in July 2014. Richie had used the drug for two years. Theresa also filed for loss of consortium.

The Actos bladder cancer lawsuit stated, “Defendants failed to warn Plaintiffs or their treating physicians and healthcare providers that there is a reasonable association of Actos to bladder cancer and heart damage.”

It is because of this failure to warn that the plaintiffs used Actos in the first place. The Actos bladder cancer lawsuits have claimed that they would have chosen safer treatment options had they been informed about Actos bladder cancer and other Actos complications.

About Actos

Actos was approved by the FDA in 1999 to treat type-2 diabetes. It was created jointly by Eli Lilly and Takeda North America. In 2006, Takeda ended that partnership, leaving Eli Lilly to be the primary company behind the drug. In 2007, the FDA forced the defendants to add “congestive heart failure” to the warning label.

The Actos lawsuit states that the defendants knew or should have known that Actos could lead to bladder cancer. Studies have suggested Actos bladder cancer side effects since the early 2000’s.

The Actos bladder cancer lawsuit claims that the defendants “willfully, wantonly and with malice” hid Actos bladder cancer risks from the public which led to the pain and suffering of the plaintiffs as well as countless other individuals. Instead, the company made a sizable profit from the medication, despite the fact that some European countries were suspending Actos use due to Actos complications, they claim. 

The charges in this Actos bladder cancer lawsuit include negligence, failure to warn, defective design, breach of express and implied warranty, fraud and fraudulent concealment, spoliation, and loss of consortium.

The Actos lawsuit was added to the Actos multidistrict litigation (MDL) currently underway in a Louisiana federal court.

This Actos Bladder Cancer Lawsuit MDL is In Re: Actos Products Liability Litigation, MDL No. 6:11-2200, in the U.S. District Court for the Western District of Louisiana.

Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual Actos lawsuit or Actos class action lawsuit is best for you. [In general, Actos bladder cancer lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.

Learn More